Please try another search
STENTYS S.A., a medical technology company, develops solutions for treating patients with acute myocardial infarction and other coronary disease in Europe, the Middle East, Latin and South America, and South East Asia. Its product portfolio consists of Xposition S, a sirolimus-eluting self-apposing coronary stent system; Serpentis, a sirolimus eluting stent with a bioabsorbable polymer; MiStent SES, a sirolimus eluting absorbable polymer coronary stent system; and STENTYS AC, an aspiration catheter. The company serves interventional cardiologists. STENTYS S.A. was founded in 2006 and is based in Paris, France.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review